Bone metabolism in anorexia nervosa

Current Osteoporosis Reports

Volumn 12, Issue 1, 2014, Pages 82-89

  Fazeli, Pouneh K ^a   Klibanski, Anne ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anorexia nervosa; Bone mineral density

Indexed keywords

ADIPONECTIN; ALKALINE PHOSPHATASE BONE ISOENZYME; ESTROGEN; FIBROBLAST GROWTH FACTOR 21; GHRELIN; GONADORELIN; GROWTH HORMONE; HYDROCORTISONE; LEPTIN; LIOTHYRONINE; LUTEINIZING HORMONE; OSTEOCALCIN; PEPTIDE YY; PRASTERONE; SIRTUIN 1; SOMATOMEDIN C; TESTOSTERONE; THYROID HORMONE RECEPTOR; THYROTROPIN; THYROXINE;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; AMENORRHEA; ANOREXIA NERVOSA; BONE DENSITY; BONE MASS; BONE METABOLISM; COMORBIDITY; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENERGY EXPENDITURE; FOOD INTAKE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE RESISTANCE; HYPERTHYROIDISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOLEPTINEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INCIDENCE; OSSIFICATION; OSTEOLYSIS; PROTEIN BLOOD LEVEL; REVIEW;

ANOREXIA NERVOSA; BONE DENSITY; BONE DISEASES, METABOLIC; BONE RESORPTION; HUMAN GROWTH HORMONE; HUMANS; HYPOGONADISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; OSTEOGENESIS; PITUITARY-ADRENAL SYSTEM;

EID: 84895920114     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-013-0186-8     Document Type: Review

References (96)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV); 4th ed. Washington, DC; 1994.
2. Keski-Rahkonen A, Hoek HW, Susser ES, Linna MS, Sihvola E, Raevuori A, et al. Epidemiology and course of anorexia nervosa in the community. Am J Psychiatry. 2007;164(8):1259-65. doi:10.1176/appi.ajp.2007.06081388. (Pubitemid 47292416)
3. Lucas AR, Crowson CS, O'Fallon WM, Melton III LJ. The ups and downs of anorexia nervosa. Int J Eating Disorders. 1999;26(4): 397-405. (Pubitemid 29519642)
4. Trickey H. Eating disorders exact toll on adults, too. 2006. www.cnn.com. Accessed 15 Oct 2013.
5. Harris EC, Barraclough B. Excess mortality ofmental disorder. Br J Psychiatry. 1998;173:11-53.
6. Miller KK, Grinspoon SK, Ciampa J, Hier J, Herzog D, Klibanski A. Medical findings in outpatients with anorexia nervosa. Arch Int Med. 2005;165(5):561-6. doi:10.1001/archinte.165.5.561. (Pubitemid 40344389)
7. Grinspoon S, Thomas E, Pitts S, Gross E, Mickley D, Miller K, et al. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Int Med. 2000;133(10):790-4.
8. Lucas AR, Melton III LJ, Crowson CS, O'Fallon WM. Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin Proc. 1999;74(10):972-7. doi:10.4065/74.10.972. (Pubitemid 29471192)
9. Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR. The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA. 1991;265(9):1133-8.
10. Misra M, Tsai P, Anderson EJ, Hubbard JL, Gallagher K, Soyka LA, et al. Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. Am J Clin Nutrit. 2006;84(4):698-706. (Pubitemid 44715650)
11. Haagensen AL, Feldman HA, Ringelheim J, Gordon CM. Low prevalence of vitamin D deficiency among adolescents with anorexia nervosa. Osteoporosis Int. 2008;19(3):289-94. doi:10.1007/s00198-007-0476-z. (Pubitemid 351199188)
12. Stefanis N, Mackintosh C, Abraha HD, Treasure J, Moniz C. Dissociation of bone turnover in anorexia nervosa. Ann Clin Biochem. 1998;35(Pt 6):709-16. (Pubitemid 28523803)
13. Soyka LA, Grinspoon S, Levitsky LL, Herzog DB, Klibanski A. The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metabol. 1999;84(12):4489-96.
14. Garfinkel PE, Brown GM, Stancer HC, Moldofsky H. Hypothalamic-pituitary function in anorexia nervosa. Arch Gen Psychiatry. 1975;32(6):739-44.
15. Scacchi M, Pincelli AI, Caumo A, Tomasi P, Delitala G, Baldi G, et al. Spontaneous nocturnal growth hormone secretion in anorexia nervosa. J Clin Endocrinol Metabol. 1997;82(10):3225-9. (Pubitemid 27419061)
16. Stoving RK, Veldhuis JD, Flyvbjerg A, Vinten J, Hangaard J, Koldkjaer OG, et al. Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis. J Clin Endocrinol Metabol. 1999;84(6):2056-63. (Pubitemid 30647033)
17. Misra M, Miller KK, Bjornson J, Hackman A, Aggarwal A, Chung J, et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metabol. 2003;88(12):5615-23. (Pubitemid 38033024)
18. Grinspoon SK, Baum HB, Peterson S, Klibanski A. Effects of rhIGF-I administration on bone turnover during short-term fasting. J Clin Invest. 1995;96(2):900-6. doi:10.1172/JCI118137.
19. Counts DR, Gwirtsman H, Carlsson LM, Lesem M, Cutler Jr GB. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metabol. 1992;75(3):762-7.
20. Hotta M, Fukuda I, Sato K, Hizuka N, Shibasaki T, Takano K. The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa. J Clin Endocrinol Metabol. 2000;85(1):200-6. (Pubitemid 32268814)
21. Gianotti L, Pincelli AI, Scacchi M, Rolla M, Bellitti D, Arvat E, et al. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa. J Clin Endocrinol Metabol. 2000;85(8):2805-9. (Pubitemid 32269156)
22. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, et al.Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol. 2001;145(5): 669-73.
23. Misra M, Miller KK, Herzog DB, Ramaswamy K, Aggarwal A, Almazan C, et al. Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metabol. 2004;89(4):1605-12. (Pubitemid 38507909)
24. Misra M, Miller KK, Kuo K, Griffin K, Stewart V, Hunter E, et al. Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metabol. 2005;289(2):E347-56. doi:10.1152/ajpendo.00615.2004. (Pubitemid 41076638)
25. Zhao TJ, Liang G, Li RL, Xie X, Sleeman MW, Murphy AJ, et al. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restrictedmice. Proc Natl Acad Sci U S A. 2010;107(16):7467-72. doi:10.1073/pnas.1002271107.
26. Gahete MD, Cordoba-Chacon J, Luque RM, Kineman RD. The rise in growth hormone during starvation does not serve to maintain glucose levels or lean mass but is required for appropriate adipose tissue response in female mice. Endocrinology. 2013;154(1):263-9. doi:10.1210/en.2012-1849.
27. Nakasaki M, Yoshioka K, Miyamoto Y, Sasaki T, Yoshikawa H, Itoh K. IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts. Bone. 2008;43(5):869-79. doi:10.1016/j.bone.2008.07.241.
28. Canalis E. Effect of insulinlike growth factor I on DNA and protein synthesis in cultured rat calvaria. J Clin Invest. 1980;66(4):709-19. doi:10.1172/JCI109908. (Pubitemid 10060939)
29. Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metabol. 2002;87(6):2883-91. (Pubitemid 34655358)
30. Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metabol. 1996;81(11):3864-70. (Pubitemid 26380388)
31. Misra M, McGrane J, Miller KK, Goldstein MA, Ebrahimi S, Weigel T, et al. Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa. Bone. 2009;45(3):493-8. doi:10.1016/j.bone. 2009.06.002.
32. Nishimura T, Nakatake Y, Konishi M, Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta. 2000;1492(1):203-6. (Pubitemid 30349198)
33. Zhang X, Yeung DC, Karpisek M, Stejskal D, Zhou ZG, Liu F, et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes. 2008;57(5):1246-53. doi:10.2337/db07- 1476.
34. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, et al. FGF-21 as a novelmetabolic regulator. J Clin Invest. 2005;115(6):1627-35. doi:10.1172/JCI23606.
35. Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metabol. 2007;5(6):415-25. doi:10.1016/j.cmet.2007.05.003. (Pubitemid 46825496)
36. Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ, Kliewer SA. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metabol. 2008;8(1):77-83. doi:10.1016/j.cmet.2008.05.006.
37. Fazeli PK, Misra M, Goldstein M, Miller KK, Klibanski A. Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. J Clin Endocrinol Metabol. 2010;95(1): 369-74. doi:10.1210/jc.2009-1730.
38. Gillum MP, Erion DM, Shulman GI. Sirtuin-1 regulation of mammalian metabolism. Trends Molec Med. 2010;17(1):8-13. doi:10.1016/j.molmed.2010.09.005.
39. Yamamoto M, Iguchi G, Fukuoka H, Suda K, Bando H, Takahashi M, et al. SIRT1 regulates adaptive response of the growth hormone-insulin-like growth factor-I axis under fasting conditions in liver. Proc Natl Acad Sci U S A. 2013;110(37):14948-53. doi:10.1073/pnas.1220606110.
40. Baxter RC, Turtle JR. Regulation of hepatic growth hormone receptors by insulin. Biochem Biophys Res Commun. 1978;84(2):350-7. (Pubitemid 9023895)
41. Leung KC, Doyle N, Ballesteros M, Waters MJ, Ho KK. Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. J Clin Endocrinol Metabol. 2000;85(12):4712-20. (Pubitemid 32157657)
42. Boyar RM, Katz J, Finkelstein JW, Kapen S, Weiner H, Weitzman ED, et al. Anorexia nervosa. Immaturity of the 24-hour luteinizing hormone secretory pattern. N Engl J Med. 1974;291(17):861-5.
43. Wiegelmann W, Solbach HG. Effects of LH-RH on plasma levels of LH and FSH in anorexia nervosa. Horm Metab Res. 1972;4(5): 404. doi:10.1055/s-0028- 1097104.
44. Mecklenburg RS, Loriaux DL, Thompson RH, Andersen AE, Lipsett MB. Hypothalamic dysfunction in patients with anorexia nervosa. Medicine. 1974;53(2):147-59.
45. Travaglini P, Beck-Peccoz P, Ferrari C, Ambrosi B, Paracchi A, Severgnini A, et al. Some aspects of hypothalamic-pituitary function in patients with anorexia nervosa. Acta Endocrinol (Copenh). 1976;81(2):252-62.
46. Nillius SJ, Fries H, Wide L. Successful induction of follicular maturation and ovulation by prolonged treatment with LH-releasing hormone in women with anorexia nervosa. Am J Obstet Gynecol. 1975;122(8):921-8.
47. Riis BJ, Rodbro P, Christiansen C. The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis. Calcif Tissue Int. 1986;38(6):318-22. (Pubitemid 16081448)
48. Klibanski A, Biller BM, Schoenfeld DA, Herzog DB, Saxe VC. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metabol. 1995;80(3):898-904.
49. •• Misra M, Katzman D, Miller KK, Mendes N, Snelgrove D, Russell M, et al. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Min Res. 2011;26(10):2430-8. doi:10.1002/jbmr.447. Demonstrates an increase in bone mineral density in response to physiologic estrogen replacement in adolescent girls with anorexia nervosa.
50. van Binsbergen CJ, Coelingh Bennink HJ, Odink J, Haspels AA, Koppeschaar HP. A comparative and longitudinal study on endocrine changes related to ovarian function in patients with anorexia nervosa. J Clin Endocrinol Metabol. 1990;71(3):705-11.
51. Miller KK, Lawson EA, Mathur V, Wexler TL, Meenaghan E, Misra M, et al. Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metabol. 2007;92(4):1334-9. doi:10.1210/jc.2006-2501. (Pubitemid 46556406)
52. •• Miller KK, Meenaghan E, Lawson EA, Misra M, Gleysteen S, Schoenfeld D, et al. Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metabol. 2011;96(7):2081-8. doi:0.1210/jc.2011-0380. Demonstrates an increase in bone mineral density in response to one year of bisphosphonate therapy in anorexia nervosa. The 2%-4% increase in bone mineral density is the greatest increase reported to date in response to a treatment in women with anorexia nervosa.
53. Zumoff B, Walsh BT, Katz JL, Levin J, Rosenfeld RS, Kream J, et al. Subnormal plasma dehydroisoandrosterone to cortisol ratio in anorexia nervosa: a second hormonal parameter of ontogenic regression. J Clin Endocrinol Metabol. 1983;56(4):668-72. (Pubitemid 13165428)
54. Gordon CM, Goodman E, Emans SJ, Grace E, Becker KA, Rosen CJ, et al. Physiologic regulators of bone turnover in young women with anorexia nervosa. J Pediatrics. 2002;141(1):64-70. doi:10. 1067/mpd.2002.125003.
55. Gordon CM, Grace E, Emans SJ, Feldman HA, Goodman E, Becker KA, et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metabol. 2002;87(11):4935-41. (Pubitemid 35316328)
56. Divasta AD, Feldman HA, Giancaterino C, Rosen CJ, Leboff MS, Gordon CM. The effect of gonadal and adrenal steroid therapy on skeletal health in adolescents and young women with anorexia nervosa. Metabolism. 2012;61(7):1010-20. doi:10.1016/j.metabol.2011.11.016.
57. Misra M, Miller KK, Almazan C, Ramaswamy K, Lapcharoensap W, Worley M, et al. Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metabol. 2004;89(10):4972-80. doi:10.1210/jc.2004-0723. (Pubitemid 39391436)
58. Lawson EA, Donoho D, Miller KK, Misra M, Meenaghan E, Lydecker J, et al. Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metabol. 2009;94(12):4710-6. doi:10.1210/jc.2009-1046.
59. Misra M, Klibanski A. The neuroendocrine basis of anorexia nervosa and its impact on bone metabolism. Neuroendocrinology. 2011;93(2):65-73. doi:10.1159/000323771.
60. Boyar RM, Hellman LD, Roffwarg H, Katz J, Zumoff B, O'Connor J, et al. Cortisol secretion and metabolism in anorexia nervosa. N Engl J Med. 1977;296(4):190-3. doi:10.1056/NEJM197701272960403.
61. Canalis E. Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metabol. 1996;81(10):3441-7. (Pubitemid 26339895)
62. Rauch A, Seitz S, Baschant U, Schilling AF, Illing A, Stride B, et al. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metabol. 2010;11(6):517-31. doi:10.1016/j.cmet.2010.05.005.
63. McCarthy TL, Centrella M, Canalis E. Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells. Endocrinology. 1990;126(3):1569-75. (Pubitemid 20095765)
64. Urena P, Iida-Klein A, Kong XF, Juppner H, Kronenberg HM, Abou-Samra AB, et al. Regulation of parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid by glucocorticoids and PTH in ROS 17/2.8 and OK cells. Endocrinology. 1994;134(1):451-6. (Pubitemid 24022024)
65. Padmanabhan V, Keech C, Convey EM. Cortisol inhibits and adrenocorticotropin has no effect on luteinizing hormone-releasing hormone-induced release of luteinizing hormone from bovine pituitary cells in vitro. Endocrinology. 1983;112(5): 1782-7. (Pubitemid 13049340)
66. Moshang Jr T, Parks JS, Baker L, Vaidya V, Utiger RD, Bongiovanni AM, et al. Low serum triiodothyronine in patients with anorexia nervosa. J Clin Endocrinol Metabol. 1975;40(3): 470-3.
67. Miyai K, Yamamoto T, Azukizawa M, Ishibashi K, Kumahara Y. Serum thyroid hormones and thyrotropin in anorexia nervosa. J Clin Endocrinol Metabol. 1975;40(2):334-8.
68. Croxson MS, Ibbertson HK. Low serum triiodothyronine (T3) and hypothyroidism in anorexia nervosa. J Clin Endocrinol Metabol. 1977;44(1):167-74. (Pubitemid 8030797)
69. Leslie RD, Isaacs AJ, Gomez J, Raggatt PR, Bayliss R. Hypothalamo-pituitary-thyroid function in anorexia nervosa: influence of weight gain. Br Med J. 1978;2(6136):526-8. (Pubitemid 8400333)
70. Casper RC, Frohman LA. Delayed TSH release in anorexia nervosa following injection of thyrotropin-releasing hormone (TRH). Psychoneuroendocrinology. 1982;7(1):59-68. (Pubitemid 12122257)
71. Kiyohara K, Tamai H, Takaichi Y, Nakagawa T, Kumagai LF. Decreased thyroidal triiodothyronine secretion in patients with anorexia nervosa: influence of weight recovery. Am J Clin Nutrit. 1989;50(4):767-72. (Pubitemid 19252733)
72. Onur S, Haas V, Bosy-Westphal A, Hauer M, Paul T, Nutzinger D, et al. L-tri-iodothyronine is a major determinant of resting energy expenditure in underweight patients with anorexia nervosa and during weight gain. Eur J Endocrinol. 2005;152(2):179-84. doi: 10.1530/eje.1.01850. (Pubitemid 40309562)
73. Moore R, Mills IH. Serum T3 and T4 levels in patients with anorexia nervosa showing transient hyperthyroidism during weight gain. Clin Endocrinol. 1979;10(5):443-9. (Pubitemid 10168381)
74. Fraser SA, Anderson JB, Smith DA, Wilson GM. Osteoporosis and fractures following thyrotoxicosis. Lancet. 1971;1(7707):981-3.
75. Kindblom JM, Gevers EF, Skrtic SM, Lindberg MK, Gothe S, Tornell J, et al. Increased adipogenesis in bone marrow but decreased bone mineral density in mice devoid of thyroid hormone receptors. Bone. 2005;36(4):607-16. doi:10.1016/j.bone.2005.01.017.19 (Pubitemid 40602254)
76. Bredella MA, Fazeli PK, Miller KK, Misra M, Torriani M, Thomas BJ, et al. Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metabol. 2009;94(6):2129-36. doi:10.1210/jc.2008-2532.
77. Abu EO, Bord S, Horner A, Chatterjee VK, Compston JE. The expression of thyroid hormone receptors in human bone. Bone. 1997;21(2):137-42. (Pubitemid 27395400)
78. Miell JP, Taylor AM, Zini M, Maheshwari HG, Ross RJ, Valcavi R. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins. J Clin Endocrinol Metabol. 1993;76(4):950-5. (Pubitemid 23110844)
79. Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E, et al. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metabol. 1996;81(11):3861-3. (Pubitemid 26380387)
80. Misra M, Miller KK, Kuo K, Griffin K, Stewart V, Hunter E, et al. Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metabol. 2005;289(3):E373-81. doi:10.1152/ajpendo.00041.2005. (Pubitemid 41192692)
81. Miller KK, Grinspoon S, Gleysteen S, Grieco KA, Ciampa J, Breu J, et al. Preservation of neuroendocrine control of reproductive function despite severe undernutrition. J Clin Endocrinol Metabol. 2004;89(9):4434-8. doi:10.1210/jc.2004-0720. (Pubitemid 39244451)
82. Legroux-Gerot I, Vignau J, Biver E, Pigny P, Collier F, Marchandise X, et al. Anorexia nervosa, osteoporosis and circulating leptin: the missing link. Osteoporosis Int. 2010;21(10):1715-22. doi:10.1007/s00198-009-1120-x.
83. Lawson EA, Miller KK, Bredella MA, Phan C, Misra M, Meenaghan E, et al. Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone. 2010;46(2):458-63. doi:10.1016/j.bone.2009.09.005.
84. Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM, et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med. 2004;351(10):987-97. doi:10.1056/NEJMoa040388. (Pubitemid 39166262)
85. Misra M, Miller KK, Tsai P, Gallagher K, Lin A, Lee N, et al. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metabol. 2006;91(3):1027-33. doi:10.1210/jc.2005-1878. (Pubitemid 43357776)
86. Utz AL, Lawson EA, Misra M, Mickley D, Gleysteen S, Herzog DB, et al. Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone. 2008;43(1):135-9. doi:10.1016/j.bone.2008.03.007.
87. Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM, et al. Hypothalamic Y2 receptors regulate bone formation. J Clin Invest. 2002;109(7):915-21. doi:10.1172/JCI14588.
88. Misra M, Prabhakaran R, Miller KK, Goldstein MA, Mickley D, Clauss L, et al. Prognostic indicators of changes in bone density measures in adolescent girls with anorexia nervosa-II. J Clin Endocrinol Metabol. 2008;93(4):1292-7. doi:10.1210/jc.2007-2419. (Pubitemid 351519723)
89. Fukushima N, Hanada R, Teranishi H, Fukue Y, Tachibana T, Ishikawa H, et al. Ghrelin directly regulates bone formation. J Bone Min Res. 2005;20(5):790-8. doi:10.1359/JBMR.041237. (Pubitemid 40571636)
90. Misra M, Miller KK, Stewart V, Hunter E, Kuo K, Herzog DB, et al. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metabol. 2005;90(9):5082-7. doi:10.1210/jc.2005- 0512. (Pubitemid 41262258)
91. Misra M, Miller KK, Cord J, Prabhakaran R, Herzog DB, Goldstein M, et al. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metabol. 2007;92(6):2046-52. doi:10.1210/jc.2006-2855. (Pubitemid 46997099)
92. Tagami T, Satoh N, Usui T, Yamada K, Shimatsu A, Kuzuya H. Adiponectin in anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metabol. 2004;89(4):1833-7. (Pubitemid 38507941)
93. Housova J, Anderlova K, Krizova J, Haluzikova D, Kremen J, Kumstyrova T, et al. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metabol. 2005;90(3):1366-70. doi:10.1210/jc.2004-1364. (Pubitemid 40463989)
94. Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD, et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Min Res. 2006;21(10):1648-56. doi:10.1359/jbmr.060707. (Pubitemid 44484610)
95. Lowe B, Zipfel S, Buchholz C, Dupont Y, Reas DL, Herzog W. Long-term outcome of anorexia nervosa in a prospective 21-year follow-up study. Psycholog Med. 2001;31(5):881-90. (Pubitemid 32621896)
96. Miller KK, Lee EE, Lawson EA, Misra M, Minihan J, Grinspoon SK, et al. Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metabol. 2006;91(8):2931-7. doi:10. 1210/jc.2005-2818.